Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) EPS (Basic): 2011-2025

Historic EPS (Basic) for Adma Biologics (ADMA) over the last 12 years, with Sep 2025 value amounting to $0.15.

  • Adma Biologics' EPS (Basic) changed negligibly% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.88, marking a year-over-year increase of 203.45%. This contributed to the annual value of $0.85 for FY2024, which is 753.85% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' EPS (Basic) is $0.15, which was up 7.14% from $0.14 recorded in Q2 2025.
  • Adma Biologics' EPS (Basic)'s 5-year high stood at $0.48 during Q4 2024, with a 5-year trough of -$0.16 in Q1 2021.
  • Over the past 3 years, Adma Biologics' median EPS (Basic) value was $0.11 (recorded in 2025), while the average stood at $0.10.
  • As far as peak fluctuations go, Adma Biologics' EPS (Basic) slumped by 33.33% in 2023, and later soared by 1,400.00% in 2024.
  • Over the past 5 years, Adma Biologics' EPS (Basic) (Quarterly) stood at -$0.07 in 2021, then climbed by 14.29% to -$0.06 in 2022, then crashed by 33.33% to -$0.08 in 2023, then skyrocketed by 700.00% to $0.48 in 2024, then remained steady at $0.15 in 2025.
  • Its last three reported values are $0.15 in Q3 2025, $0.14 for Q2 2025, and $0.11 during Q1 2025.